Blind versus visual endometrial ablation: a randomised controlled trial

Completed

• Conditions: Women's health - reproductive disease; Urological and Genital Diseases; Excessive, frequent and irregular menstruation

• Registration Number: ISRCTN43442156
• Lead Sponsor: HS Grampian Endowments (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2010-07-29
• Last Update Posted: 17 October 2016

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 220

Inclusion Criteria

1. Patients eligible for endometrial ablation and be willing to be randomised to either treatment
2. Normal endometrial biopsy results
3. Uterine cavity less than 12 cm
4. Completed their family, use reliable contraception and otherwise be acceptant of hysterectomy
5. A pre-operative ultrasound scan must confirm they are suitable for either MEA or HTA
6. Pre-operative data, 1-year and 5-year data will be taken

Exclusion Criteria

1. Desire for further family
2. Abnormal endometrial pathology
3. Uterine cavity > 12 cm
4. Normal or light periods
5. Previous classical caesarean section/myomectomy/hysterotomy
6. Previous caesarean section scar less than 10 mm
7. Acute uterine infection

Study & Design

• Study Type: Interventional
• Study Design: Not specified